Cargando…

Activated monocytes and markers of inflammation in newly diagnosed multiple sclerosis

In multiple sclerosis (MS), the inflammation and demyelination of the central nervous system (CNS) develop in distinct ways. This makes diagnosing patients difficult, imperative to initiating early and proper treatment. Several common features exist, among them a profound infiltration of monocytes i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carstensen, Mikkel, Christensen, Tove, Stilund, Morten, Møller, Holger J, Petersen, Eva L, Petersen, Thor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496724/ https://www.ncbi.nlm.nih.gov/pubmed/32253768 http://dx.doi.org/10.1111/imcb.12337

Ejemplares similares

Subsets of activated monocytes and markers of inflammation in incipient and progressed multiple sclerosis
por: Gjelstrup, Mikkel Carstensen, et al.
Publicado: (2017)

Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel
por: Stilund, Morten, et al.
Publicado: (2015)

Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis
por: Stilund, Morten, et al.
Publicado: (2014)

A multi‐biomarker follow‐up study of patients with multiple sclerosis
por: Stilund, Morten, et al.
Publicado: (2016)

B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity
por: Brudek, Tomasz, et al.
Publicado: (2009)

Pathogenesis of multiple sclerosis: expression of HERV-Fc1: a human endogenous retrovirus
por: Laska, Magdalena Janina, et al.
Publicado: (2011)

Absence of xenotropic murine leukaemia virus-related virus in Danish patients with multiple sclerosis
por: Maric, Romana, et al.
Publicado: (2011)

Expression of HERV-H/W env epitopes on PBMCs from MS patients with active disease
por: Brudek, Tomasz, et al.
Publicado: (2011)

Study protocol: randomised controlled trial evaluating exercise therapy as a supplemental treatment strategy in early multiple sclerosis: the Early Multiple Sclerosis Exercise Study (EMSES)
por: Riemenschneider, Morten, et al.
Publicado: (2021)

Vaccination frequency in people newly diagnosed with multiple sclerosis
por: Darvishi, Sonia, et al.
Publicado: (2023)

A parallel-group randomized clinical trial of individually tailored, multidisciplinary, palliative rehabilitation for patients with newly diagnosed advanced cancer: the Pal-Rehab study protocol
por: Nottelmann, Lise, et al.
Publicado: (2017)

Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study
por: Mynster Kronborg, Thit, et al.
Publicado: (2023)

Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker
por: Zahran, Asmaa M., et al.
Publicado: (2021)

Oxidative Stress Markers in Cerebrospinal Fluid of Newly Diagnosed Multiple Sclerosis Patients and Their Link to Iron Deposition and Atrophy
por: Burgetova, Andrea, et al.
Publicado: (2022)

Serum Short-Chain Fatty Acids and Associations With Inflammation in Newly Diagnosed Patients With Multiple Sclerosis and Healthy Controls
por: Olsson, Anna, et al.
Publicado: (2021)

Immunological Subsets Characterization in Newly Diagnosed Relapsing–Remitting Multiple Sclerosis
por: D’Amico, Emanuele, et al.
Publicado: (2022)

Treatment Courses of Patients Newly Diagnosed with Multiple Sclerosis in 2012–2018
por: Sipilä, Jussi O. T.
Publicado: (2023)

Corrigendum: Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker
por: Zahran, Asmaa M., et al.
Publicado: (2022)

Quality of life in multiple sclerosis: The differential impact of motor and cognitive fatigue
por: David Ruban, Sabina, et al.
Publicado: (2021)

Newly Diagnosed Amyotrophic Lateral Sclerosis in a Patient with Multiple-System Atrophy
por: Choi, Moonkyung, et al.
Publicado: (2020)

MRI-derived g-ratio and lesion severity in newly diagnosed multiple sclerosis
por: York, Elizabeth N, et al.
Publicado: (2021)

Sedentary time and markers of inflammation in people with newly diagnosed type 2 diabetes
por: Falconer, C.L., et al.
Publicado: (2014)

Inflammation Markers in Multiple Sclerosis: CXCL16 Reflects and May Also Predict Disease Activity
por: Holmøy, Trygve, et al.
Publicado: (2013)

Peripheral Blood Lymphocyte-to-Monocyte Ratio as a Useful Prognostic Factor in Newly Diagnosed Multiple Myeloma
por: Tian, Ying, et al.
Publicado: (2018)

Significance of the absolute lymphocyte/monocyte ratio as a prognostic immune biomarker in newly diagnosed multiple myeloma
por: Dosani, T, et al.
Publicado: (2017)

Urinary Markers of Nucleic Acid Oxidation and Long-Term Mortality of Newly Diagnosed Type 2 Diabetic Patients
por: Broedbaek, Kasper, et al.
Publicado: (2011)

Is serum vitamin D levels associated with disability in patients with newly diagnosed multiple sclerosis?
por: Hatamian, Hamidreza, et al.
Publicado: (2013)

Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States
por: Kern, David M., et al.
Publicado: (2020)

Newly Diagnosed Multiple Sclerosis Presenting as Brown-Séquard Syndrome: A Case Report
por: Hoebee, Shelby, et al.
Publicado: (2022)

Innate and adaptive anti-viral immune responses in MS patients treated with interferon-beta
por: Petersen, Thor, et al.
Publicado: (2011)

Citrullination of Histone H3 Interferes with HP1-Mediated Transcriptional Repression
por: Sharma, Priyanka, et al.
Publicado: (2012)

Clinical Significance of Systemic Inflammation Markers in Newly Diagnosed, Previously Untreated Hepatocellular Carcinoma
por: Yu, Jeong Il, et al.
Publicado: (2020)

Adipocytokines in Untreated Newly Diagnosed Rheumatoid Arthritis: Association with Circulating Chemokines and Markers of Inflammation
por: Vasileiadis, Georgios K., et al.
Publicado: (2021)

Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population
por: Sørrig, Rasmus, et al.
Publicado: (2017)

Newly diagnosed multiple sclerosis in a patient with ocular myasthenia gravis: A case report
por: Bong, Jeong Bin, et al.
Publicado: (2022)

Cardiac Autonomic Imbalance in Newly Diagnosed and Established Diabetes Is Associated with Markers of Adipose Tissue Inflammation
por: Lieb, David C., et al.
Publicado: (2012)

The Etiology of Multiple Sclerosis: Genetic Evidence for the Involvement of the Human Endogenous Retrovirus HERV-Fc1
por: Nexø, Bjørn A., et al.
Publicado: (2011)

Development and usability testing of a patient decision aid for newly diagnosed relapsing multiple sclerosis patients
por: Bansback, Nick, et al.
Publicado: (2019)

Cortical Thickness and Serum NfL Explain Cognitive Dysfunction in Newly Diagnosed Patients With Multiple Sclerosis
por: Cruz-Gomez, Álvaro J., et al.
Publicado: (2021)

Association of cerebrospinal inflammatory profile with radiological features in newly diagnosed treatment-naïve patients with multiple sclerosis
por: Ashida, Shinji, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tgjto8tg32g2dpbhafv95e75oc